BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target boosted by equities researchers at Piper Sandler ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Argus has a "buy" rating and $115 price target for STT stock, which closed at $98.61 on Feb. 11. Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 4.83% to 5.83%.